Ed Ridley-Day
Stock Analyst at Rothschild & Co
(n/a)
# 5,013
Out of 5,182 analysts
9
Total ratings
n/a
Success rate
-27.73%
Average return
Main Sectors:
Stocks Rated by Ed Ridley-Day
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Neutral | $42 | $45.60 | -7.89% | 1 | Jan 12, 2026 | |
| DHR Danaher | Downgrades: Neutral | $245 → $220 | $189.61 | +16.03% | 1 | Oct 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $130 | $93.12 | +39.60% | 1 | Sep 18, 2025 | |
| SYK Stryker | Initiates: Neutral | $420 | $339.15 | +23.84% | 1 | Sep 18, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | n/a | $40.89 | - | 1 | Apr 4, 2025 | |
| LNTH Lantheus Holdings | Initiates: Buy | $175 | $80.59 | +117.15% | 1 | Sep 3, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Buy | $380 → $510 | $450.62 | +13.18% | 2 | Aug 2, 2024 | |
| GEHC GE HealthCare Technologies | Initiates: Buy | n/a | $73.18 | - | 1 | Jan 19, 2023 |
Medline
Jan 12, 2026
Initiates: Neutral
Price Target: $42
Current: $45.60
Upside: -7.89%
Danaher
Oct 8, 2025
Downgrades: Neutral
Price Target: $245 → $220
Current: $189.61
Upside: +16.03%
Zimmer Biomet Holdings
Sep 18, 2025
Initiates: Buy
Price Target: $130
Current: $93.12
Upside: +39.60%
Stryker
Sep 18, 2025
Initiates: Neutral
Price Target: $420
Current: $339.15
Upside: +23.84%
Qiagen
Apr 4, 2025
Downgrades: Neutral
Price Target: n/a
Current: $40.89
Upside: -
Lantheus Holdings
Sep 3, 2024
Initiates: Buy
Price Target: $175
Current: $80.59
Upside: +117.15%
Intuitive Surgical
Aug 2, 2024
Upgrades: Buy
Price Target: $380 → $510
Current: $450.62
Upside: +13.18%
GE HealthCare Technologies
Jan 19, 2023
Initiates: Buy
Price Target: n/a
Current: $73.18
Upside: -